TALZENNA is the first and only PARP inhibitor approved in combination with standard of care…
Pfizer has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental…
The University of Rochester will house a new national center focused on using tissue-on-chip technology to develop…
Researchers have discovered that a protein called phosphorylated α-synuclein, which is associated with several neurodegenerative…
Like the Greek mythological beast with a snake’s tail and two ferocious heads, a potential…
Sylvester-Led Research Group Unveils the First Individual Risk Prediction Model for Multiple Myeloma
A multicenter collaboration led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller…
People around the world eat too much sugar. When the body is unable to process…
The FTC is pursuing rulemaking around health data security and privacy. Here’s why it matters…
Merck and Harpoon Therapeutics today announced that the companies have entered into a definitive agreement…
Contraceptive use is low among reproductive-aged people with disabilities who are enrolled in Medicare, according…
